Bioxcel Therapeutics shares owned by Bank of New York Mellon
Quarter-by-quarter ownership of Bioxcel Therapeutics (BTAI) shares owned by Bank of New York Mellon
from 13F filings
Historical chart of Bank of New York Mellon investment in Bioxcel Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Bioxcel Therapeutics held by Bank of New York Mellon consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Bioxcel Therapeutics by Bank of New York Mellon
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-03-31 | $347k | 123k | 2.82 |
2023-12-31 | $373k | 127k | 2.95 |
2023-09-30 | $324k | 128k | 2.53 |
2023-06-30 | $753k | 113k | 6.66 |
2023-03-31 | $1.4M | 77k | 18.66 |
2022-12-31 | $1.5M | 72k | 21.48 |
2022-09-30 | $824k | 65k | 12.63 |
2022-06-30 | $802k | 61k | 13.18 |
2022-03-31 | $1.2M | 58k | 20.87 |
2021-12-31 | $1.1M | 57k | 20.00 |
2021-09-30 | $1.6M | 54k | 30.36 |
2021-06-30 | $1.4M | 50k | 29.07 |
2021-03-31 | $2.6M | 61k | 43.13 |
2020-12-31 | $2.9M | 62k | 46.20 |
2020-09-30 | $2.4M | 56k | 43.34 |
2020-06-30 | $2.8M | 53k | 52.63 |
2020-03-31 | $1.1M | 50k | 22.38 |
2019-12-31 | $284k | 19k | 14.61 |
2019-09-30 | $142k | 19k | 7.31 |
2019-06-30 | $198k | 18k | 10.96 |